TO STUDY COMPLIANCE OF ANTENATAL WOMEN IN RELATION TO IRON SUPPLEMENTATION IN ROUTINE ANTE-NATAL CLINIC AT A TERTIARY HEALTH CARE CENTRE by Godara, Sushila et al.
Godara et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(3), 71-75   71 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
Available online at http://jddtonline.info 
RESEARCH ARTICLE 
TO STUDY COMPLIANCE OF ANTENATAL WOMEN IN RELATION TO IRON 




, Dr Hooda Ritu
2
, Dr Nanda Smiti
3
, Dr Mann Sonika
4
 
1Senior Resident, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India 
2Associate Professor, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India 
3Senior Professor, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India 
4Assistant Professor, Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India 





















Anemia is the commonest medical disorder in pregnancy. 
Its prevalence may be as high as 88% in some parts of 
India1.Anaemia especially if severe is directly or indirectly 
responsible for 40% of maternal deaths2.Iron deficiency is 
the most prevalent single nutritional deficiency, nearly 
50% of women with iron deficiency progress to iron 
deficiency anemia3.However, the prevalence of iron 
deficiency in women has decreased over past several 
decades and this has been variously attributed to several 
factors like prophylactic iron, iron supplements, better 
health care and public health programs, but above all, in a 
large measure to iron fortification4.  
WHO defines anaemia as hemoglobin concentration less 
than11 gram%. The gross iron requirement in pregnancy is 
about 1240mg elemental iron that include obligate losses 
(230mg), red cell mass expansion (450mg), fetal 
requirement (270mg), placental tissue (90mg) and loss at 
delivery (200mg). A healthy pregnant woman can obtain 
half of this requirement from her balanced diet especially 
as iron absorption increases in pregnancy and about 150mg 
is saved because of amenorrhoea that leaves a net 
requirement of about 500mg, which can be obtained, from 
presumably adequate iron stores of a healthy woman. But 
most of our women are already anaemic, with deficient 
iron store sand poor dietary habits. As a result, pregnancy 
worsens the anemia and causes unwanted complications. 
The Government of India in the National Nutritional 
Anemia Control Program has recommended daily intake of 
100mg elemental iron with 500 micrograms of folic acid in 
the second half of the pregnancy for at least 100 days. Oral 
iron therapy has poor patient compliance either due to side 
effects or forgetfulness. In a recent study it was seen that 
injectable iron in two divided doses has better compliance 
and good results5.  
Relation of Iron and diet — As we knows that iron taken 
in the form of diet which is rich in meat, grains, green 
leafy vegetables etc. is important in preventing iron 
deficiency anemia. In a diet having 2000 calorie, it is 
important to note that there is only about 10 mg of 
elemental iron (compared to 65 mg in one 325 mg iron 
sulfate tablet). For treatment of iron deficiency anemia, 
dietary iron with vitamin C or drinking orange juice with 
high iron foods which enhances the iron absorption is 
recommended in combination with iron therapy.   
Compliance may be defined as the extent to which 
behavior of the subject coincides with medical or health 
advice. It involves patient and doctor compliance. Patient 
compliance with drug therapy can be defined as the extent 
to which the patient follows a prescribed drug regimen. It 
involves whether the patients follows recommendations 
made by the provider with respect to timing, dosage, and 
frequency of medication taking.  It also includes whether 
the patient follows   diet schedule, attends clinics regularly 
or follows other instructions given by the doctor. Doctor’s 
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compliance is the extent to which the behavior of the 
doctor fulfills their professional duty i.e to prescribe 
accurately, to give proper instructions to the patients and to 
adopt new advances when they are sufficiently proved.6-7 
Compliance is measured over a period of time and reported 
as a percentage. Compliance is a behavioral response to 
clinical treatment. Compliance may be complete, partial, 
erratic, nil or there may be over compliance. Over 
compliance refers to intake of drug by the patients more 
than prescribed, even increasing the dose by 50%. Typical 
compliance rates for prescribed medications are about 50% 
with a range of 0% to more than 100%.8  Compliance has 
little relation to socio-demographic factors such as age, 
race, intelligence but education of the patient seems to 
improve compliance, and would be expected to do so. For 
example, reminders as diary, mobile phone, calendar pack 
to take the treatment can improve compliance. In addition, 
patients tend to miss appointments and drop out of care 
when there are long waiting times at clinics or long time 
lapses between appointments. Finally, compliance 
decreases as the complexity, cost, and duration of the 
regimen increase. As treatment response is related to the 
dose
 
and schedule of a therapy, noncompliance reduces 
treatment benefits and can affect assessment of the 
effectiveness of treatments. 9-11 In addition to its potential 
for undermining the effectiveness of any treatment, 
noncompliance is associated with poorer prognosis.12 
Numerous studies have demonstrated that inadequate 
compliance with prescribed medication regimens results in 
increased morbidity and mortality from a wide variety of 
illnesses, as well as increased health-care costs.13-14  
To improve compliance, antenatal women needs to know 
the degree of the anaemia i.e  she is suffering from i.e 
mild, moderate and severe type, symptoms of anaemia & 
the medication prescribed for the treatment of the disease. 
She must understand the benefits of the iron, diet & all the 
instructions given by the doctor especially the frequency, 
duration and the time at which medication should be taken. 
She must be well aware of the side effects and any 
significant drug interactions with the food, alcohol or any 
other medicine. 15 With increasing numbers of effective 
self-administered treatments, the need is apparent for better 
understanding and management of noncompliance. The 
problem of low compliance has posed a challenge to many 
nutrition program implementors and health practitioners. 
Studies have been conducted to experiment on new 
formulations of medicinal iron or modification of the 
regimen from daily to weekly dosage in order to increase 
complance to iron supplementation.16,17 It was commented 
that the ―issue at hand is not whether a weekly iron dose is 
beneficial or not, but whether pregnant women are able to 
receive and take iron tablets as prescribed‖.18 
To the best of our knowledge there is no research 
conducted to reveal the extent of this problem in Haryana. 
Therefore we believe that this research may show the 
magnitude of problem in Haryana so as to initiate 
intervention by the concerned authorities and the 
community as well. 
AIMS AND OBJECTIVES 
1. Compliance in relation to intake of iron 
supplementation and dietary advice. 
2. Factors affecting the compliance in ante-natal 
women.(Parity, age, education, degree of anaemia, 
any intervention for anaemia in previous years, 
knowledge of anemia i.e cause, symptom, effect, 
treatment and prevention of anemia).  
MATERIAL AND METHODS 
STUDY AREA 
The study site is Rohtak city of Haryana state in India i.e 
OPD, Gynecology and Obstetrics Department, PGIMS 
Rohtak and anganwari center nearest to PGIMS Rohtak . 
STUDY DESIGN AND POPULATION: 
This is a cross sectional study carried out on 1000 
antenatal pregnant women (16wks-30wks) who are 
routinely attending the ante-natal clinic. Compliance in 
this study defined as the adherence of pregnant women to 
the practice of daily intake of iron tablets for 90 
consecutive days.  
DATA COLLECTION AND MANAGEMENT: 
A structured and pretested questionnaire was used to 
collect the information. It was prepared in English and 
then translated to local language. The answer of each 
question had two rating scales: yes and no. The collected 
variables included:  economic condition of the women, 
age, profession, education,  obestetric history, antenatal 
complications due to medical or pregancy related causes,  
questionnaire on antenatal pregnant women compliance 
such as did she know the symptoms of iron 
deficiency(weakness, headache, irritability, difficulty in 
exercising, pallor complexion ,rapid heartbeat), did you 
take the iron tablets as advised, did you follow the 
instructions given by the doctor, did  she follow the oral 
iron supplementation and diet schedule, did you know the 
degree of anemia(mild, moderate, severe), did you take 
any intervention for treatment of anaemia in previous 
pregnancies( Inj. Iron i/m or i/v, any blood transfusion), 
did you attended  the antenatal clinic regularly. If the 
antenatal women stopped taking the medication whether it 
was  due to any side effects (Nausea, vomiting, gastric 
upset, constipation, unpleasant taste), long term taking of 
iron tablets/not liking pharmaceutical preparations(tablet) 
but likes other preparations as liquid, forgetfullness, not 
liking due to poor quality of iron tablet supplied by 
government and did you stop the iron tablets because of 
suffering from antenatal complications and  taking 
medicine for other diseases also ( AIDS, hypothyroidism, 
tuberculosis, heart disease etc.). Data was collected from 
the antenatal women and analysed.  Results are represented 
in the form of percentages and tables. Questionnaire is 
attached as appendix-1. 
RESULTS:  
A total of 1000 pregnant women were screened and 
enrolled in the study between October 2011 – September 
2012. Of the 1000 pregnant women screened, 840 pregnant 
women included in the study. Rest 160 women were not 
able to finish the study required, thus, were excluded in the 
data analysis. The reasons were:  pregnant women lost 
interest to continue with the study, transfer of residence, 
miscarriage, ectopic pregnancy etc. 
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Total 19 questionnaires were asked to the 840 pregnant 
women to check the antenatal compliance. Most of the 
pregnant women were in younger age group i.e 20-30 
years(65%),  followed by middle and elderly age group i.e 
30-43years(35%). Middle and elderly women were slightly 
more compliant than younger age group i.e 54.62% versus 
45.38%. About half of the pregnant women (54 %) were 
homemaker. Sixteen percent were private staff while 
government staffs were 30%. Women in private and 
government staffs were slightly more compliant than 
homemaker 55.78% versus 44.22%.  Out of total pregnant 
women 60% were educated and 40% uneducated. The 
compliance were better observed in educated women as 
compared to uneducated i.e 62.14 vs 37.86%. Multiparous 
women were more compliant than nulliparous i.e 59.39% 
vs 40.61%. According to socioeconomic status 30% 
pregnant women belonged to middle socioeconomic group, 
41% from low socioeconomic group whereas only 29% 
were from higher socioeconomic strata. Compliance was 
best observed in high socioeconomic group of women as 
compared to middle and lower socioeconomic group i.e. 
45.38% versus 29.77% versus 24.85% respectively as 
shown in table 1. 
Pregnant women with pregnancy complications due to 
antenatal causes and medical causes were slightly less 
compliant than routinely antinatal care pregnant women 
78.5% vs 80%.  The pregnant women attended the 
antenatal clinic regularly were 76%. Most of the pregnant 
women (80%) understood the symptoms of anemia they 
were suffering from, only 18% had knowledge about the 
degree of anemia i.e mild, moderate and severe. The 
women having the knowledge about anemia were 27%. 
Almost all pregnant women believed that doctor had nicely 
explained about the iron deficiency anemia, the anticipated 
benefits from the iron tablets and the instructions for the 
intake of iron tablets and diet. 80% of the pregnant women 
believed that the pharmacist and nurse explained the 
instructions for intake of medicine and they followed also. 
Those pregnant women who followed the instructions, 
took the iron tablets and diet as advised were 80.47% 
(compliance).  The pregnant women who stopped taking 
the medication because of side effects were 29.03% 
(Gastric upset 10.2%, vomiting 4.6%, nausea 8%, 
constipation 4.4%, unpleasant taste 2.1%) and due to 
suffering from pregnancy complications and taking 
multiple drug supplements  were 22.58% ,long term taking 
of iron tablets were 19.35%, not liking pharmaceutical 
preparations were 16.94%, forgetfullness were 9.68% and 
not liking due to poor quality of iron tablet supplied by 
government were 2.42% respectively (non compliance) 
while 5.11% of the pregnant women increased the dose of 
iron tablets themselves for additional benefits or to have 
quicker response (over compliance) as shown in table 2 
and 3. 
Table 1: Compliance of pregnant Women according to Sociodemographic profile: 
 Characterstics                                          Number                       Percentage(%) 
 Age in years 
     20-30                                                       314                                 45.38 
     30-40                                                       378                                 54.62 
Occupation 
Homemaker                                                  306                                44.22 
Working private/govt.                                  386                                55.78 
Education  status 
Educated                                                       430                                62.14 
Uneducated                                                   262                                37.86 
Parity 
Nulliparous                                                   281                                 40.61 
Multiparous                                                  411                                  59.39 
Socioeconomic status 
High                                                             314                                  45.38 
Middle                                                         206                                   29.77 
Low                                                             172                                   24.85 
 
TABLE 2        Compliance in relation to oral iron and diet 
 Antenatal Women                                          Number                 Percentage (%) 
  Compliant                                                                  692                            80.47 
 Non Compliant                                                           124                            14.42 
Over Compliant                                                            44                             5.11 
 
TABLE 3   Frequency and percentage of reasons of non compliance of pregnant women regarding iron 
supplementation 
  Causes                                                               Frequency                   Percentage (%) 
Side effects                                                                 36                                            29.03 
Suffering from pregnancy complications                   28                                            22.58                                                                                        
Long term taking of iron tablets                                 24                                            19.35 
Not liking pharmaceutical preparations                     21                                            16.94 
 Forgetfulness                                                             12                                             9.68                                                                                                                                 
Poor quality of tablet supplied by govt.                     3                                               2.42                
 
Godara et al                                Journal of Drug Delivery & Therapeutics; 2013, 3(3), 71-75   74 
© 2011, JDDT. All Rights Reserved                                                        ISSN: 2250-1177                                                     CODEN (USA): JDDTAO 
DISCUSSION 
Compliance with iron supplementation plays a major role 
in the prevention and treatment of iron deficiency anemia 
particularly among pregnant women whose iron 
requirement starts at the second trimester and progresses 
until the third trimester. Eight hundred forty pregnant 
women in the City of Haryana participated in the present 
study to determine compliance with iron supplementation 
as well as factors that may have influenced compliance. 
Pregnant women compliance describes the degree to which 
a women correctly follows medical advice. Non-
compliance is a major obstacle to the effective delivery of 
health care. Prevalence of compliance in this study was 
80.47% as these pregnant women understood and strictly 
followed the instructions given by the doctor while 5.11% 
of the pregnant women were over compliant and 14.42% 
of the pregnant women were non-compliant but the study 
conducted by Lertmulligaporn N  found that the 
compliance rate was about 75%.19 
In the present study, elderly and middle women were 
slightly more compliant than younger age group. The 
reason for this is that they may be more concerned about 
their health than younger patients and they get necessary 
support and cooperation from their family members and 
had better behaviors in prevention and treatment of iron 
deficiency anemia in pregnant women. . The findings of 
our studies were in accordance with study shown by 
Boonserm K.20 
         In the present study compliance was better observed 
in educated and high economic status pregnant women as 
compared to uneducated. It may be because of the fact that 
women with higher educational level have better 
knowledge about the iron deficiency anemia and therapy 
and therefore are more compliant. Similar results were 
reported by Brand et al (1977).21 The pregnant women 
with good knowledge had  good compliance. In our study 
it was observed that the number of pregnant women who 
stopped taking the medication because of side effects were 
36 out of total 840 participated in the study(4.28%) but in 
Burma only 3% of women stated that side effects were the 
reason they stopped taking iron supplements while 30% of 
women in Thailand complained of side effects while 
taking iron tablets.22 Although there is little evidence to 
suggest side effects are a major deterrent to compliance 
with iron supplementation, they should not be ignored and 
consideration of them should be part of the treatment 
plan.23In our study it was observed that some women  not 
liking due to poor quality of iron tablet supplied by 
government, the study done by  Rao also demonstrated 
similar results.24   Our study shows that 80% of the women 
believed that the pharmacist and nurse explained the 
instructions for intake of medicine to them and they 
followed those instructions. The study done by Sipkoff 
also demonstrated that the pharmacists were responsible 
for adjusting drug regimens as well as identifying and 
preventing drug-related problems. The study found that 
this type of pharmacist intervention improved 
compliance.25 
CONCLUSION 
This study shows that  compliance is related to education 
of the pregnant women and proper explanation of 
instructions by doctor, pharmacist and nurses, help to 
improve the compliance but much can be done to improve 
existing iron supplementation programs in developing 
countries by ensuring that iron tablets of good quality are 
available at all levels of health care. To further increase 
compliance of pregnant women with iron supplementation, 
health workers should establish a good health provider-
patient relationship that can help in motivating pregnant 
women to regularly take their iron supplements. Complete 
instructions, such as the dosage and manner of taking the 
iron tablets, the benefits of iron tablets and diet rich in 
iron, the side effects that may be experienced from taking 
the iron tablets, and what women should do when 
experiencing side effects, should always be communicated 
to pregnant women. 
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                                                     APPENDIX – 1 
 
QUESTIONNAIRE 
Antinatal women compliance report 
Name:                                                       Age:                             W/0 : 
Profession:                                               Apparent income group: low/middle/high 
Address:                                                   Education level:                                                   
   
Obestetric history:  Date of last menstrual period, period of gestation, parity, live issues, abortions, previous LSCS, ectopic 
pregancy, infertility. 
Antenatal complications: 
1. Medical cause: Thyroid dysfunction, anaemia, viral hepatitis, diabetes mellitis, heart diseases, STS/AIDS, tuberculosis, 
syphilis, malaria, asthema, haematuria etc. 
2. Pregancy related: pre-eclampsia, gestational diabetes mellitis, intrauterine growth retardation, oligohydramnios, 
antipartum haemorrhage etc. 
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1. Did you visit the antenatal clinic regularly as advised?                               Yes/No   
2. Did you know the symptom of iron deficiency anaemia ?                           Yes/no    
3. Did you know the degree of anaemia( mild,moderate,severe)?                   Yes /No                                                               
4. Did you investigate for iron deficiency anaemia(Hb) ?                               Yes/No 
5. Did you take any intervention for treatment of anaemia as inj.Iron or blood transfusion in previous pregancy?                                                                                      
Yes/No            
6. Did you have knowledge of anemia?                                                            Yes/No 
7. Do  you understand how much time required  for treatment of the Iron deficiency anaemia?                         Yes/No                                                        
8. Did the doctor explain that what benefits you can have from iron tablet?     Yes/No                                                                                          
9. Did the doctor give you some instructions for the intake of iron tablet?       Yes/No                                                                                  
10. Do you understand and follow the instructions given by the doctors (dose, duration, schedule e.g OD, BD, HS)?  
                                                                                                                              Yes/No  
11. Did you take iron tablets and diet as advised?                                                 Yes/No 
12. Did you stop the iron tablet because of any side effects?                                Yes/No 
13. Did you stop the iron tablet due to suffering from antenatal complication?    Yes/No            
14. Did you stop the iron tablet because of  long term taking of iron tablets ?      Yes/No            
15. Did you stop the iron tablet because not liking pharmaceutical preparations? 
16.  Did you stop the iron tablet forgetfullness?                                                    Yes/No            
17. Did you stop the iron tablet because not liking due to poor quality of iron tablet supplied by government?     Yes/No                                                                                                   
18. Did you increase the dose of iron tablet yourself for additional benefits or to have quicker response?              Yes/No                                       
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